The biologics market was valued at US$328.617 billion in 2020 and will increase to US$735.219 billion by 2027. Over the forecast period, this market is estimated to increase at a compound yearly growth rate of 12.19%. Biologics, commonly referred to as biological medications, are disease-modifying antirheumatic drugs that are manufactured from live organisms or contain living species components. Vaccines, blood, blood components, cells, genes, tissues, allergies, and recombinant proteins are among the products derived from living beings, animals, birds, insects, plants, and microorganisms. These products regulate the development of essential proteins, alter human hormones and cells, and produce compounds that either stimulate or suppress the immune system. They also alter the way basic biologics intracellular & cellular activities function. Biologics have exploded in popularity in recent years because they are used to treat a wide range of diseases and ailments, including Crohn'
Showing posts with the label biologics market